Shopping Cart
- Remove All
- Your shopping cart is currently empty
HPK1-IN-28, a potent inhibitor of HPK1, enhances anti-tumor immunity in humans and demonstrates research potential in immune-related diseases, particularly tumors, by acting as a negative regulator of dendritic cell (DC), T-cell, and B-cell activation responses.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | HPK1-IN-28, a potent inhibitor of HPK1, enhances anti-tumor immunity in humans and demonstrates research potential in immune-related diseases, particularly tumors, by acting as a negative regulator of dendritic cell (DC), T-cell, and B-cell activation responses. |
Molecular Weight | 513.47 |
Formula | C25H22F3N5O4 |
Cas No. | 2699603-89-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.